Our Mission

NASCSA's mission is to support, equip, and advocate for state controlled substances authorities, prescription monitoring program administrators, and other members in their work to advance the public's health, safety and welfare.

Visit NASCSA forum/newsgroup

Important News & Announcements

DEA Diversion Control Division to Launch a New Website

Posted 11/16/2023

DEA?s Diversion Control Division is getting ready to launch a new website. We would love your feedback.

Here is a sneak peek at the new site, still under development: https://test.deadiversion.usdoj.gov/. Let us know what you think!

Read More

DEA Increases Production Quota to Manufacture Medication to Treat Attention Deficit Disorder

Posted 10/1/2023

To address shortages of methylphenidate HCl extended-release tablets, a common drug used to treat attention deficit disorder (ADD), attention deficit hyperactivity disorder (ADHD), and narcolepsy, DEA will raise the amount that may be produced.

On Sept. 29, DEA Administrator Anne Milgram...
Read More

Healthcare Distribution Alliance Job Opportunity

Posted 9/26/2023

The Healthcare Distribution Alliance (HDA) is expanding its state government affairs team and currently recruiting for a director-level position in Illinois or Wisconsin. If you know anyone who might be interested in the position, they are encouraged to apply for the position through...
Read More

Complimentary Webinar Available

Posted 9/24/2023

Recent Hospital Controlled Substance Diversion Cases ? Cautionary Tales

Tuesday, October 3, 2023: 12:00-12:45

Hyman, Phelps & McNamara (HPM) invites you to join...
Read More

FDA Delays Enforcement of Drug Supply Chain Security Act

Posted 8/29/2023

WASHINGTON, DC ? Yesterday (August 28, 2023) The Food and Drug Administration announced that it was postponing its plans to enforce the Drug Supply Chain Security Act, slated to go into effect in late November. In its announcement FDA indicated it will not take action until...
Read More

All news & announcements

Sponsor Spotlight

COMPASS Pathways

COMPASS Pathways is delighted to be a sponsor of NASCSA and looks forward to both engaging with controlled substances authorities, NASCSA leadership, and members to learn about their important work, and educate about our company's mission and the innovations underway using novel therapies.

COMPASS Pathways is a mental health care company dedicated to accelerating patient access to evidence-based innovation in mental health. Our focus is on improving the lives of those who are suffering with mental health challenges and who are not helped by current treatments.

We are developing innovative therapies and, when appropriate, combining them with psychological support and next-generation digital tools to forge new, sustainable mental health care pathways.

Our investigational COMP360 psilocybin therapy is currently undergoing phase 3 investigation in treatment-resistant depression. We are also assessing COMP360 in anorexia nervosa and post-traumatic stress disorder, across multiple clinical studies.

Learn more https://www.compasspathways.com

All Sponsors

State Controlled Substance and PMP Database

Click on a state to access the controlled substance and PMP database. Available information includes PMP and controlled substance contact information as well as PMP profiles. The database contains the most current information that is available to us.

Please use this form to contact Shannon Tonn

* Please do not submit patient health information (PHI).